Enabling Tailored Cancer Care For Patients
Cancer Care is Still Hit or Miss
Current diagnostic approaches, including genomic testing, cannot tell with accuracy whether a cancer therapy will be effective.
But There Is Hope -
SAGE Oncotest™
The SAGE Oncotest™ evaluates a curated list of FDA-approved drugs assessing their potential for treating a wide range specific cancers.
- Solid tumors such as ovarian cancer, pancreatic cancer, or brain cancer.
- Solid tumor of unknown origin.
- Blood cancers such as multiple myeloma.
Getting Started With SAGE Is Easy
STEP 1.
Contact us prior to surgery or biopsy and we will coordinate with your physician.
STEP 2.
A fresh tissue is taken during surgery or biopsy and shipped to SAGE.
STEP 3.
Receive your SAGE Oncotest™ Report to significantly improve the effectiveness of your treatment.
When Should You Order The SAGE Oncotest™
Well Before Your Surgery
If surgery is scheduled and subsequent treatment is required, contact us now to coordinate a fresh tumor specimen from your surgery.
If Your Treatment Fails
If treatment isn’t working anymore, contact us today! Our SAGE Oncotest™ can help the oncology team understand what to avoid for more promising treatment options.
Who is eligible for the SAGE Oncotest™?
The SAGE Oncotest™ is intended for patients with solid tumors, especially those facing aggressive, late-stage, metastatic, or recurrent disease. It is most helpful when treatment decisions involve chemotherapy, targeted therapy, or other systemic options.
You may be eligible if:
- You have a solid tumor,
- You are scheduled for surgery or a biopsy that can provide fresh, live tumor tissue, and
- You will likely require chemo- or targeted therapy.
Is the SAGE Oncotest™ Right for Me?
While the SAGE Oncotest™ can be used for most types of solid tumors, a physician’s prescription is required.
To quickly check whether you might qualify and benefit from the test, we recommend taking this 5 min questionnaire.
Which Cancers Can the SAGE Oncotest™ Test?
The SAGE Oncotest™ can test almost all cancers, including:
- Ovarian and other gynecological cancers;
- Triple negative, BRCA positive, metastatic, and other aggressive breast cancers;
- Colorectal and other gastro-intestinal cancers;
- Glioblastoma and other aggressive brain cancers.
- Cancers of unknown origin (cancers of unknown primary, CUPs) and other rare cancers.
The SAGE Oncotest™ is not indicated for:
- Very slow growing cancers of limited clinical relevance, e.g. low-grade breast or prostate cancers.
- Early cancers where surgical excision is generally curative, e.g. small skin cancers, small (hazelnut size or smaller) breast cancers.
If I already had a biopsy or surgery, can we use that tissue or do I need another biopsy for the SAGE Oncotest™?
The SAGE Oncotest™ works with fresh, live tissue to see how your cancer responds to different medications. Thus, if you already had a previous biopsy or surgery, your sample was most likely placed into a preservative (e.g., in formalin) and subsequently paraffin embedded to cut and stain thin slices (histological slides, aka pathology), so that tissue will be dead and can no longer be used for the SAGE Oncotest™.
However, if you’re scheduled for a new procedure, you can ask your doctor to collect fresh tissue for the test to be sent to SageMedic. Just be aware that some cancer centers may claim ownership of excised tissue in their consent forms, so it’s important to communicate your intent ahead of time.